OCUL insider transactions
Ocular Therapeutix Inc. (OCUL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for OCUL
- Chief Medical Officer Waheed Nadia sold $122,628 worth of shares (14,828 units at $8.27), decreasing direct ownership by 5% to 300,079 units (SEC Form 4) (tax liability)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin received a gift of 394,696 shares, sold $173,479 worth of shares (21,156 units at $8.20) and gifted 394,696 shares, decreasing direct ownership by 0.81% to 2,597,170 units (SEC Form 4) to cover taxes4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $24,329 worth of shares (2,967 units at $8.20), decreasing direct ownership by 1% to 266,141 units (SEC Form 4) to satisfy withholding obligation4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $24,748 worth of shares (3,018 units at $8.20), decreasing direct ownership by 0.93% to 320,350 units (SEC Form 4) to cover withholding tax4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $15,236 worth of shares (1,858 units at $8.20), decreasing direct ownership by 0.56% to 328,795 units (SEC Form 4) to satisfy withholding obligation4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- SEC Form 4 filed by Dugel Pravin4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin sold $166,064 worth of shares (20,056 units at $8.28), decreasing direct ownership by 0.66% to 3,013,022 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $23,267 worth of shares (2,810 units at $8.28), decreasing direct ownership by 1% to 269,108 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $25,312 worth of shares (3,057 units at $8.28), decreasing direct ownership by 0.94% to 323,368 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $14,565 worth of shares (1,759 units at $8.28), decreasing direct ownership by 0.53% to 330,653 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Medical Officer Waheed Nadia sold $27,167 worth of shares (3,510 units at $7.74), decreasing direct ownership by 1% to 314,907 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Operating Officer Notman Donald sold $103,472 worth of shares (11,446 units at $9.04), decreasing direct ownership by 3% to 366,356 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $93,546 worth of shares (10,348 units at $9.04), decreasing direct ownership by 3% to 332,412 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin sold $1,128,933 worth of shares (124,882 units at $9.04), decreasing direct ownership by 4% to 3,033,078 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Medical Officer Waheed Nadia sold $71,082 worth of shares (7,863 units at $9.04), decreasing direct ownership by 2% to 318,417 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Operating Officer Notman Donald sold $101,398 worth of shares (11,490 units at $8.82), decreasing direct ownership by 3% to 377,802 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Global CCO Robinson David Wayne was granted 136,000 shares (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- SEC Form 3 filed by new insider Robinson David Wayne3 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- SEC Form 4 filed by Interim CFO Robins Jason Shand4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- New insider Robins Jason Shand claimed ownership of 52,656 shares (SEC Form 3)3 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Legal Officer Anderman Todd was granted 64,900 shares, increasing direct ownership by 74% to 152,468 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Commercial Officer Meyers Steve Lawrence was granted 64,900 shares, increasing direct ownership by 42% to 217,628 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay was granted 64,900 shares, increasing direct ownership by 23% to 342,760 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter was granted 79,112 shares, increasing direct ownership by 41% to 271,918 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Business Officer Saroj Namrata was granted 79,112 shares, increasing direct ownership by 45% to 254,620 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Medical Officer Waheed Nadia was granted 79,112 shares, increasing direct ownership by 32% to 326,280 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. was granted 79,112 shares, increasing direct ownership by 32% to 326,425 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Notman Donald was granted 79,112 shares, increasing direct ownership by 26% to 389,292 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $22,611 worth of shares (1,878 units at $12.04), decreasing direct ownership by 0.67% to 277,860 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin sold $235,141 worth of shares (19,530 units at $12.04), gifted 49,754 shares and received a gift of 49,754 shares, decreasing direct ownership by 0.61% to 3,157,960 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $36,144 worth of shares (3,007 units at $12.02), decreasing direct ownership by 2% to 191,433 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $41,767 worth of shares (3,469 units at $12.04), decreasing direct ownership by 1% to 245,940 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Business Officer Saroj Namrata sold $277,790 worth of shares (25,865 units at $10.74), decreasing direct ownership by 13% to 174,135 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Legal Officer Anderman Todd sold $137,369 worth of shares (11,132 units at $12.34), decreasing direct ownership by 11% to 87,568 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $106,473 worth of shares (9,653 units at $11.03), decreasing direct ownership by 5% to 194,440 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $115,942 worth of shares (10,502 units at $11.04), decreasing direct ownership by 4% to 249,409 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin gifted 49,754 shares and received a gift of 49,754 shares, decreasing direct ownership by 2% to 3,177,490 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Notman Donald sold $13,250 worth of shares (1,066 units at $12.43), decreasing direct ownership by 0.34% to 308,807 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $36,252 worth of shares (3,011 units at $12.04), decreasing direct ownership by 1% to 204,093 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $22,695 worth of shares (1,885 units at $12.04), decreasing direct ownership by 0.67% to 279,738 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $36,879 worth of shares (3,063 units at $12.04), decreasing direct ownership by 1% to 259,911 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin sold $258,788 worth of shares (21,494 units at $12.04), decreasing direct ownership by 0.66% to 3,227,244 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Medical Officer Waheed Nadia was granted 40,363 shares, increasing direct ownership by 20% to 247,168 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin gifted 250,361 shares and received a gift of 250,361 shares, decreasing direct ownership by 7% to 3,248,738 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- New insider Meyers Steve Lawrence claimed ownership of 152,728 shares (SEC Form 3)3 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- New insider Saroj Namrata claimed ownership of 200,000 shares (SEC Form 3)3 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- SEC Form 4 filed by Officer Dugel Pravin4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Hong Seung Suh was granted 14,000 shares, increasing direct ownership by 43% to 46,933 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Raines Merilee was granted 14,000 shares, increasing direct ownership by 43% to 46,933 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Lindstrom Richard L Md was granted 14,000 shares, increasing direct ownership by 11% to 143,145 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Williams Leslie J. was granted 14,000 shares, increasing direct ownership by 37% to 51,433 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Warden Charles M was granted 14,000 shares, increasing direct ownership by 19% to 86,464 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Graves Adrienne L was granted 14,000 shares, increasing direct ownership by 39% to 50,000 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Medical Officer Waheed Nadia sold $111,581 worth of shares (13,861 units at $8.05), decreasing direct ownership by 6% to 206,805 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Strategy Officer Nayak Sanjay sold $13,351 worth of shares (1,862 units at $7.17), decreasing direct ownership by 0.66% to 281,623 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Development Officer Kaiser Peter sold $21,324 worth of shares (2,974 units at $7.17), decreasing direct ownership by 1% to 207,104 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Chief Scientific Officer Heier Jeffrey S. sold $21,712 worth of shares (3,024 units at $7.18), decreasing direct ownership by 1% to 262,974 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Officer Dugel Pravin sold $152,352 worth of shares (21,219 units at $7.18), decreasing direct ownership by 0.60% to 3,499,099 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)
- Director Lindstrom Richard L Md bought $69,600 worth of shares (10,000 units at $6.96), increasing direct ownership by 6% to 172,704 units (SEC Form 4)4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)